NASDAQ:CHRS
$4.35
(
1.40%
)
Friday, 26th May 2023
Coherus BioSciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.16 | $8.22 | Friday, 26th May 2023 CHRS stock ended at $4.35. This is 1.4% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 6.23% from a day low at $4.26 to a day high of $4.52. |
| 90 days | $4.16 | $8.65 | |
| 52 weeks | $4.16 | $14.11 |
Historical Coherus BioSciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $4.35 | $4.52 | $4.26 | $4.35 | 2 447 445 |
| 2023-05-25 | $4.40 | $4.40 | $4.16 | $4.29 | 2 443 778 |
| 2023-05-24 | $4.52 | $4.56 | $4.31 | $4.34 | 2 280 030 |
| 2023-05-23 | $4.46 | $4.72 | $4.40 | $4.56 | 3 887 341 |
| 2023-05-22 | $4.53 | $4.58 | $4.37 | $4.46 | 2 175 930 |
| 2023-05-19 | $4.76 | $4.76 | $4.39 | $4.54 | 2 907 645 |
| 2023-05-18 | $4.95 | $5.01 | $4.42 | $4.51 | 4 591 978 |
| 2023-05-17 | $5.22 | $5.30 | $4.78 | $5.02 | 4 671 609 |
| 2023-05-16 | $4.58 | $5.31 | $4.56 | $5.18 | 9 425 350 |
| 2023-05-15 | $4.89 | $5.11 | $4.80 | $4.89 | 1 601 022 |
| 2023-05-12 | $5.17 | $5.17 | $4.85 | $4.90 | 2 086 338 |
| 2023-05-11 | $5.91 | $5.91 | $5.17 | $5.19 | 2 928 387 |
| 2023-05-10 | $5.93 | $6.17 | $5.45 | $5.91 | 3 755 229 |
| 2023-05-09 | $6.46 | $6.52 | $5.81 | $5.91 | 4 860 011 |
| 2023-05-08 | $7.41 | $8.22 | $7.27 | $8.14 | 1 835 141 |
| 2023-05-05 | $7.38 | $7.60 | $7.27 | $7.38 | 574 735 |
| 2023-05-04 | $7.26 | $7.67 | $7.07 | $7.32 | 551 444 |
| 2023-05-03 | $7.28 | $7.48 | $7.11 | $7.30 | 749 366 |
| 2023-05-02 | $7.62 | $7.68 | $7.13 | $7.17 | 1 004 803 |
| 2023-05-01 | $7.49 | $8.00 | $7.39 | $7.67 | 1 006 475 |
| 2023-04-28 | $7.20 | $7.37 | $7.09 | $7.23 | 497 846 |
| 2023-04-27 | $7.55 | $7.63 | $7.21 | $7.24 | 572 505 |
| 2023-04-26 | $7.80 | $7.90 | $7.46 | $7.51 | 902 004 |
| 2023-04-25 | $8.01 | $8.13 | $7.71 | $7.78 | 528 598 |
| 2023-04-24 | $8.31 | $8.33 | $7.99 | $8.06 | 402 757 |
| 2023-04-21 | $7.99 | $8.31 | $7.95 | $8.30 | 622 433 |
| 2023-04-20 | $8.05 | $8.24 | $7.87 | $7.97 | 626 196 |
| 2023-04-19 | $8.06 | $8.34 | $8.02 | $8.15 | 551 761 |
| 2023-04-18 | $8.29 | $8.29 | $7.78 | $8.17 | 778 319 |
| 2023-04-17 | $8.00 | $8.65 | $7.95 | $8.23 | 1 327 681 |
| 2023-04-14 | $8.36 | $8.36 | $7.72 | $7.88 | 699 553 |
| 2023-04-13 | $7.81 | $8.14 | $7.67 | $8.13 | 811 292 |
| 2023-04-12 | $8.00 | $8.00 | $7.69 | $7.70 | 843 301 |
| 2023-04-11 | $7.84 | $7.97 | $7.58 | $7.80 | 561 637 |
| 2023-04-10 | $7.67 | $7.94 | $7.63 | $7.84 | 1 658 081 |
| 2023-04-06 | $7.65 | $7.74 | $7.58 | $7.66 | 724 039 |
| 2023-04-05 | $7.43 | $7.82 | $7.38 | $7.68 | 758 571 |
| 2023-04-04 | $7.50 | $7.62 | $7.26 | $7.45 | 1 419 949 |
| 2023-04-03 | $6.81 | $7.51 | $6.53 | $7.48 | 1 072 185 |
| 2023-03-31 | $6.51 | $6.86 | $6.51 | $6.84 | 1 095 669 |
| 2023-03-30 | $6.50 | $6.56 | $6.36 | $6.43 | 1 156 272 |
| 2023-03-29 | $6.49 | $6.54 | $6.31 | $6.48 | 918 872 |
| 2023-03-28 | $6.34 | $6.55 | $6.28 | $6.42 | 1 265 051 |
| 2023-03-27 | $6.05 | $6.18 | $5.97 | $6.00 | 757 658 |
| 2023-03-24 | $5.89 | $6.08 | $5.81 | $6.00 | 704 562 |
| 2023-03-23 | $6.00 | $6.10 | $5.81 | $5.90 | 1 117 951 |
| 2023-03-22 | $6.11 | $6.17 | $5.87 | $5.89 | 1 147 149 |
| 2023-03-21 | $6.31 | $6.36 | $6.05 | $6.10 | 907 148 |
| 2023-03-20 | $6.03 | $6.34 | $5.99 | $6.26 | 937 922 |
| 2023-03-17 | $6.35 | $6.44 | $6.05 | $6.08 | 2 111 078 |
About Coherus BioSciences
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
